Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

819
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
819
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

752
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
752
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

3.7K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
3.7K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

6.2K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
6.2K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

2.0K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Collision Sports: The Need for Further Education in Rugby.

Cureus·2026
Same author

Homer, Hippocrates, and modern military warfare: The helmet dilemma continues.

Medical journal, Armed Forces India·2026
Same author

Presumptive mivacurium chloride-associated histamine release resulting in overt tissue edema during endoscopic thyroidectomy: a report of two cases.

BMC anesthesiology·2026
Same author

Women's Health in Rugby: It Is More Than Orthopedics.

Cureus·2026
Same author

Insights From Michael Polanyi: Tacit Knowledge and Its Critical Importance in Medical Education.

Cureus·2026
Same author

The Effects of Vitamin D Replacement with a High-Dose Treat-to-Goal Strategy.

Nutrients·2026

Related Experiment Video

Updated: Jan 4, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.3K

An Artificial Neural Network-based Predictive Model to Support Optimization of Inpatient Glycemic Control.

Scott M Pappada1,2,3, Mohammad Hamza Owais4, Brent D Cameron2

  • 1Department of Anesthesiology, University of Toledo, College of Medicine and Life Sciences, Toledo, Ohio.

Diabetes Technology & Therapeutics
|November 6, 2019
PubMed
Summary

A new neural network model accurately predicts blood glucose levels in critical care patients up to 135 minutes in advance. This advancement aids in optimizing glycemic control, reducing complications, and improving patient outcomes in intensive care units (ICUs).

Keywords:
Clinical decision supportGlycemic controlIntensive care unitMachine learningPredictive models

More Related Videos

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.4K
A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

784

Related Experiment Videos

Last Updated: Jan 4, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.3K
A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.4K
A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

784

Area of Science:

  • Biomedical Engineering
  • Artificial Intelligence in Medicine
  • Critical Care Medicine

Background:

  • Glycemic control is crucial for reducing mortality and morbidities in critical care patients.
  • Maintaining optimal blood glucose levels is challenging due to diverse patient conditions in the ICU.
  • Accurate glucose prediction is essential for effective diabetes management in intensive care settings.

Purpose of the Study:

  • To develop and validate a predictive model for glycemic trajectories in intensive care unit (ICU) patients.
  • To assess the accuracy and clinical acceptability of a neural network-based glucose prediction model.
  • To explore the potential of the model in clinical decision support systems for glycemic management.

Main Methods:

  • Collected continuous glucose monitoring (CGM) and electronic medical record data from 127 ICU patients.
  • Developed a neural network model to predict glucose values up to 135 minutes ahead.
  • Validated model accuracy using a separate patient cohort (15 patients) to simulate real-world performance.

Main Results:

  • The neural network model demonstrated improved accuracy compared to previous methods.
  • Mean absolute percentage error was 10.6% for interstitial glucose and 15.9% for serum glucose at 135 minutes.
  • Over 99% of predictions were clinically acceptable, as per Clarke Error Grid Analysis, indicating no risk of erroneous insulin therapy.

Conclusions:

  • The developed predictive models show high accuracy and clinical acceptability for glycemic management in critical care.
  • These models have significant potential for integration into clinical decision support systems.
  • Optimization of glycemic control in ICU patients can be enhanced, potentially leading to better patient outcomes.